|
Volumn 44, Issue 4, 2010, Pages 239-245
|
Hepatocellular carcinoma (HCC): A global perspective
a b c d e h f i j k l m n r p s g o q t more..
d
HOSPITAL CLÍNIC
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETIC ACID;
AFLATOXIN;
ALCOHOL;
ALPHA FETOPROTEIN;
HEPATITIS B VACCINE;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
ANTIVIRAL THERAPY;
CHEMOEMBOLIZATION;
COMPUTER ASSISTED TOMOGRAPHY;
COST;
GENETICS;
HEALTH CARE FACILITY;
HEALTH EDUCATION;
HEPATITIS B;
HEPATITIS C;
HUMAN;
IMMUNOPATHOLOGY;
INCIDENCE;
LABORATORY TEST;
LIVER CELL CARCINOMA;
LIVER RESECTION;
LIVER TRANSPLANTATION;
MEDICAL EXPERT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
NUTRITIONAL DISORDER;
PATIENT COMPLIANCE;
PERCUTANEOUS ETHANOL INJECTION;
PHYSICAL DISEASE BY BODY FUNCTION;
PREVALENCE;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
RADIOFREQUENCY ABLATION;
REVIEW;
RISK FACTOR;
SCREENING;
TECHNIQUE;
TOBACCO;
ULTRASOUND;
CARCINOMA, HEPATOCELLULAR;
DEVELOPED COUNTRIES;
DEVELOPING COUNTRIES;
FEMALE;
HEPATITIS B, CHRONIC;
HEPATITIS C, CHRONIC;
HUMANS;
LIVER NEOPLASMS;
MALE;
PRIMARY HEALTH CARE;
RISK FACTORS;
WORLD HEALTH;
|
EID: 77949922428
PISSN: 01920790
EISSN: None
Source Type: Journal
DOI: 10.1097/MCG.0b013e3181d46ef2 Document Type: Review |
Times cited : (248)
|
References (0)
|